{"data":[{"accessionNo":"0002100119-26-001537","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience Inc","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":1970108,"percentOfClass":5.02,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001193125-26-352632","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":4176711,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001193125-26-352632","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":4176711,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001193125-26-352632","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":4176711,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000919574-26-005199","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Sirenia Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2219568,"percentOfClass":6.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000919574-26-005199","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Alex Silverstein","reportingCik":null,"personType":"HC,IN","sharesOwned":2219568,"percentOfClass":6.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000902664-26-003498","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Ryan Wilder","reportingCik":null,"personType":"HC,IN","sharesOwned":785000,"percentOfClass":2.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000902664-26-003498","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Vestal Point Capital, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":785000,"percentOfClass":2.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0002012383-26-002170","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"ALTO NEUROSCIENCE INC","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2104406,"percentOfClass":6,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000935836-26-000361","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Comon Stock","eventDate":"2026-07-13","reportingPerson":"Oleg Nodelman","reportingCik":null,"personType":"HC,IN","sharesOwned":2232000,"percentOfClass":5.8,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000935836-26-000361","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Comon Stock","eventDate":"2026-07-13","reportingPerson":"EcoR1 Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":2232000,"percentOfClass":5.8,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000935836-26-000361","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Comon Stock","eventDate":"2026-07-13","reportingPerson":"EcoR1 Capital Fund Qualified, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2065935,"percentOfClass":5.3,"filedAt":"2026-07-20","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001831942-26-000018","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Commodore Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3588180,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001831942-26-000018","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Michael Kramarz","reportingCik":null,"personType":"HC,IN","sharesOwned":3588180,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001831942-26-000018","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Robert Egen Atkinson","reportingCik":null,"personType":"HC,IN","sharesOwned":3588180,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001831942-26-000018","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Commodore Capital Master LP","reportingCik":null,"personType":"PN","sharesOwned":3588180,"percentOfClass":9.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000919574-26-003214","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Sirenia Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2591587,"percentOfClass":7.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000919574-26-003214","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Alex Silverstein","reportingCik":null,"personType":"HC,IN","sharesOwned":2591587,"percentOfClass":7.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000902664-26-002550","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Vestal Point Capital, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2064075,"percentOfClass":6.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000902664-26-002550","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Ryan Wilder","reportingCik":null,"personType":"HC,IN","sharesOwned":2064075,"percentOfClass":6.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000919574-26-003456","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":1170865,"percentOfClass":3.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000919574-26-003456","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Biotech Private Investments, LLC","reportingCik":null,"personType":"OO","sharesOwned":667778,"percentOfClass":2.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000919574-26-003456","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Differentiated Ventures Investments, LLC","reportingCik":null,"personType":"OO","sharesOwned":667778,"percentOfClass":2.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000919574-26-003456","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"72 Investment Holdings, LLC","reportingCik":null,"personType":"OO","sharesOwned":667778,"percentOfClass":2.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000919574-26-003456","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":503087,"percentOfClass":1.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000919574-26-003456","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":"02157Q109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":503087,"percentOfClass":1.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001172661-26-001305","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":1536000,"percentOfClass":4.94,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001172661-26-001305","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1536000,"percentOfClass":4.94,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001193125-26-054522","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":3249934,"percentOfClass":9.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001193125-26-054522","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":3249934,"percentOfClass":9.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001193125-26-054522","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":3249934,"percentOfClass":9.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001831942-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Michael Kramarz","reportingCik":null,"personType":"HC,IN","sharesOwned":3245628,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001831942-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Commodore Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3245628,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001831942-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Commodore Capital Master LP","reportingCik":null,"personType":"PN","sharesOwned":3245628,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001831942-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Robert Egen Atkinson","reportingCik":null,"personType":"HC,IN","sharesOwned":3245628,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000902664-26-001136","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":2824275,"percentOfClass":8.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000902664-26-001074","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Vestal Point Capital, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2485000,"percentOfClass":8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000902664-26-001074","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Ryan Wilder","reportingCik":null,"personType":"HC,IN","sharesOwned":2485000,"percentOfClass":8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000902664-26-001136","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2156497,"percentOfClass":6.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000902664-26-001136","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":2156497,"percentOfClass":6.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001172661-26-001262","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":1624000,"percentOfClass":6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001172661-26-001262","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":1624000,"percentOfClass":6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000905148-26-000894","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Anup Arora","reportingCik":null,"personType":"IN,HC","sharesOwned":788995,"percentOfClass":2.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000905148-26-000894","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Parag Shah","reportingCik":null,"personType":"IN,HC","sharesOwned":788995,"percentOfClass":2.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000905148-26-000894","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"K2 HealthVentures Equity Trust LLC","reportingCik":null,"personType":"OO","sharesOwned":788995,"percentOfClass":2.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000902664-26-001136","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Biotech Private Investments, LLC","reportingCik":null,"personType":"OO","sharesOwned":667778,"percentOfClass":2.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000902664-26-001136","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"72 Investment Holdings, LLC","reportingCik":null,"personType":"OO","sharesOwned":667778,"percentOfClass":2.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0000902664-26-001136","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Differentiated Ventures Investments, LLC","reportingCik":null,"personType":"OO","sharesOwned":667778,"percentOfClass":2.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001831942-25-000022","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-20","reportingPerson":"Commodore Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3190267,"percentOfClass":9.8,"filedAt":"2025-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001831942-25-000022","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-20","reportingPerson":"Commodore Capital Master LP","reportingCik":null,"personType":"PN","sharesOwned":3190267,"percentOfClass":9.8,"filedAt":"2025-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001831942-25-000022","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-20","reportingPerson":"Robert Egen Atkinson","reportingCik":null,"personType":"HC,IN","sharesOwned":3190267,"percentOfClass":9.8,"filedAt":"2025-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001831942-25-000022","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-20","reportingPerson":"Michael Kramarz","reportingCik":null,"personType":"HC,IN","sharesOwned":3190267,"percentOfClass":9.8,"filedAt":"2025-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001193125-25-236739","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-03","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":1989393,"percentOfClass":7.3,"filedAt":"2025-10-10","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001193125-25-236739","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-03","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":1989393,"percentOfClass":7.3,"filedAt":"2025-10-10","canonicalUrl":"https://xoomar.com/markets/stocks/anro"},{"accessionNo":"0001193125-25-236739","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001999480","issuerName":"Alto Neuroscience, Inc.","ticker":"ANRO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-03","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":1989393,"percentOfClass":7.3,"filedAt":"2025-10-10","canonicalUrl":"https://xoomar.com/markets/stocks/anro"}],"updatedAt":"2026-11-04T01:27:40.868Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/anro","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}